Nurses are vital experts to the multidisciplinary oncology team who continue to expand their role in meeting the needs of ...

UGN-102 has received FDA approval for use in patients with low-grade intermediate-risk non-muscle-invasive bladder cancer.

Advanced practice providers have the opportunity to instill hope in patients through education and personalized care.

An oral tablet formulation of zanubrutinib was approved for use in patients with certain lymphomas or leukemia and ...

Oncology nurses and APPs can help reduce discrimination faced by patients with cancer who are members of the LGBTQIA+ ...

Relacorilant plus nab-paclitaxel improved PFS and showed a trend toward longer OS in platinum-resistant ovarian cancer in ROSELLA.

Education before subcutaneous daratumumab administration can both reassure patients and reduce the occurrence of adverse ...

Adding olanzapine (Zyprexa) to a standard antiemetic regimen displayed safety and efficacy in preventing radiation-induced nausea and vomiting (RINV) for patients receiving abdominal/pelvic ...